Spectrum Pharmaceuticals Announces Promotion of Joseph Turgeon to Senior Vice President and Chief Commercial Officer as Company Builds on Recent Commercial Reorganization to Advance Growth and Market Penetration over the Next Five Years
07:00 EST 11 Jan 2013 | Businesswire
This article has expired, however you can still
download the PDF.
Preview:
Spectrum Pharmaceuticals (NasdaqGS: SPPI), a biotechnology company with
fully integrated commercial and drug development operations with a
primary focus in hematology and oncology, today announced the promotion
of Joseph Turgeon...
Other Sources for this Article
Spectrum Pharmaceuticals, Inc.
Shiv Kapoor, Vice President,
Strategic Planning & Investor Relations
702-835-6300
InvestorRelations@sppirx.com
More From BioPortfolio on "Spectrum Pharmaceuticals Announces Promotion of Joseph Turgeon to Senior Vice President and Chief Commercial Officer as Company Builds on Recent Commercial Reorganization to Advance Growth and Market Penetration over the Next Five Years"
Biotech & Healthcare Channels
World News
Life Science Events
Corporate Database
Market Reports
Categories
Search BioPortfolio:
